Assessing Perfusion in Steno-Occlusive Cerebrovascular Disease Using Transient Hypoxia-Induced Deoxyhemoglobin as a Dynamic Susceptibility Contrast Agent

References

1. 1.↵
   2. Calamante F,
   3. Ganesan V,
   4. Kirkham FJ, et al

   . MR perfusion imaging in moyamoya syndrome. Stroke 2001;32:2810–16 doi:10.1161/hs1201.099893 pmid:11739978

   Abstract/FREE Full Text
2. 2.↵
   2. Kanal E

   . Gadolinium based contrast agents (GBCA): safety overview after 3 decades of clinical experience. Magn Reson Imaging 2016;34:1341–45 doi:10.1016/j.mri.2016.08.017 pmid:27608608

   CrossRefPubMed
3. 3.↵
   2. Gulani V,
   3. Calamante F,
   4. Shellock FG, et al

   ; International Society for Magnetic Resonance in Medicine. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 2017;16:564–70 doi:10.1016/S1474-4422(17)30158-8 pmid:28653648

   CrossRefPubMed
4. 4.↵
   2. Cheng HL

   . Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. J Magn Reson Imaging 2008;28:736–43 doi:10.1002/jmri.21489 pmid:18777534

   CrossRefPubMed
5. 5.↵
   2. Calamante F,
   3. Connelly A,
   4. van Osch MJ

   . Nonlinear ΔR effects in perfusion quantification using bolus-tracking MRI. Magn Reson Med 2009;61:486–92 doi:10.1002/mrm.21839 pmid:19161169

   CrossRefPubMed
6. 6.↵
   2. Pauling L,
   3. Coryell CD

   . The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci U S A 1936;22:210–16 doi:10.1073/pnas.22.4.210 pmid:16577697

   FREE Full Text
7. 7.↵
   2. Poublanc J,
   3. Sobczyk O,
   4. Shafi R, et al

   . Perfusion MRI using endogenous deoxyhemoglobin as a contrast agent: preliminary data. Magn Reson Med 2021;86:3012–21 doi:10.1002/mrm.28974 pmid:34687064

   CrossRefPubMed
8. 8.↵
   2. Vu C,
   3. Chai Y,
   4. Coloigner J, et al

   . Quantitative perfusion mapping with induced transient hypoxia using BOLD MRI. Magn Reson Med 2021;85:168–81 doi:10.1002/mrm.28422 pmid:32767413

   CrossRefPubMed
9. 9.↵
   2. Bhogal AA,
   3. Sayin ES,
   4. Poublanc J, et al

   . Quantifying cerebral blood arrival times using hypoxia-mediated arterial BOLD contrast. Neuroimage 2022;261:119523 doi:10.1016/j.neuroimage.2022.119523 pmid:35907499

   CrossRefPubMed
10. 10.↵
    2. Schulman JB,
    3. Sayin ES,
    4. Manalac A, et al

    . DSC MRI in the human brain using deoxyhemoglobin and gadolinium: simulations and validations at 3T. Front Neuroimaging 2023;2:1048652 doi:10.3389/fnimg.2023.1048652 pmid:37554650

    CrossRefPubMed
11. 11.↵
    2. Sayin ES,
    3. Schulman J,
    4. Poublanc J, et al

    . Investigations of hypoxia-induced deoxyhemoglobin as a contrast agent for cerebral perfusion imaging. Hum Brain Mapp 2023;44:1019–29 doi:10.1002/hbm.26131 pmid:36308389

    CrossRefPubMed
12. 12.↵
    2. Slessarev M,
    3. Han J,
    4. Mardimae A, et al

    . Prospective targeting and control of end-tidal CO2 and O2 concentrations. J Physiol 2007;581:1207–19 doi:10.1113/jphysiol.2007.129395 pmid:17446225

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Fisher JA,
    3. Iscoe S,
    4. Duffin J

    . Sequential gas delivery provides precise control of alveolar gas exchange. Respir Physiol Neurobiol 2016;225:60–69 doi:10.1016/j.resp.2016.01.004 pmid:26840836

    CrossRefPubMed
14. 14.↵
    2. Cox RW

    . AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162–73 doi:10.1006/cbmr.1996.0014 pmid:8812068

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Ashburner J,
    3. Friston K

    . Multimodal image coregistration and partitioning–a unified framework. Neuroimage 1997;6:209–17 doi:10.1006/nimg.1997.0290 pmid:9344825

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Ashburner J,
    3. Friston KJ

    . Unified segmentation. Neuroimage 2005;26:839–51 doi:10.1016/j.neuroimage.2005.02.018 pmid:15955494

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Ostergaard L

    . Principles of cerebral perfusion imaging by bolus tracking. Magn Reson Imaging 2005;22:710–17 doi:10.1002/jmri.20460

    CrossRefPubMed
18. 18.↵
    2. Fantini S,
    3. Sassaroli A,
    4. Tgavalekos KT, et al

    . Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive optical methods. Neurophotonics 2016;3:031411 doi:10.1117/1.NPh.3.3.031411 pmid:27403447

    CrossRefPubMed
19. 19.↵
    2. Quarles CC,
    3. Bell LC,
    4. Stokes AM

    . Imaging vascular and hemodynamic features of the brain using dynamic susceptibility contrast and dynamic contrast enhanced MRI. Neuroimage 2019;187:32–55 doi:10.1016/j.neuroimage.2018.04.069 pmid:29729392

    CrossRefPubMed
20. 20.↵
    2. Kanda T,
    3. Ishii K,
    4. Kawaguchi H, et al

    . High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014;270:834–41 doi:10.1148/radiol.13131669 pmid:24475844

    CrossRefPubMed
21. 21.↵
    2. Buxton RB,
    3. Frank LR,
    4. Wong EC, et al

    . A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40:383–96 doi:10.1002/mrm.1910400308 pmid:9727941

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Mandell DM,
    3. Han JS,
    4. Poublanc J, et al

    . Selective reduction of blood flow to white matter during hypercapnia corresponds with leukoaraiosis. Stroke 2008;39:1993–98 doi:10.1161/STROKEAHA.107.501692 pmid:18451357

    Abstract/FREE Full Text
23. 23.↵
    2. van Gelderen P,
    3. de Zwart JA,
    4. Duyn JH

    . Pittfalls of MRI measurement of white matter perfusion based on arterial spin labeling. Magn Reson Med 2008;59:788–95 doi:10.1002/mrm.21515 pmid:18383289

    CrossRefPubMed
24. 24.↵
    2. Harris AD,
    3. Murphy K,
    4. Diaz CM, et al

    . Cerebral blood flow response to acute hypoxic hypoxia. NMR Biomed 2013;26:1844–52 doi:10.1002/nbm.3026 pmid:24123253

    CrossRefPubMed
25. 25.↵
    2. Mahamed S,
    3. Duffin J

    . Repeated hypoxic exposures change respiratory chemoreflex control in humans. J Physiol 2001;534:595–603 doi:10.1111/j.1469-7793.2001.00595.x pmid:11454975

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Mahamed S,
    3. Cunningham DA,
    4. Duffin J

    . Changes in respiratory control after three hours of isocapnic hypoxia in humans. J Physiol 2003;547:271–81 doi:10.1113/jphysiol.2002.030965 pmid:12562969

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Ren X,
    3. Dorrington KL,
    4. Robbins PA

    . Respiratory control in humans after 8 h of lowered arterial PO2, hemodilution, or carboxyhemoglobinemia. J Appl Physiol (1985) 2001;90:1189–95 doi:10.1152/jappl.2001.90.4.1189 pmid:11247913

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Nakada Y,
    3. Canseco DC,
    4. Thet S, et al

    . Hypoxia induces heart regeneration in adult mice. Nature 2017;541:222–27 doi:10.1038/nature20173 pmid:27798600

    CrossRefPubMed
29. 29.↵
    2. Almendros I,
    3. Wang Y,
    4. Gozal D

    . The polymorphic and contradictory aspects of intermittent hypoxia. Am J Physiol Lung Cell Mol Physiol 2014;307:L129–40 doi:10.1152/ajplung.00089.2014 pmid:24838748

    CrossRefPubMed
30. 30.↵
    2. Serebrovskaya TV,
    3. Manukhina EB,
    4. Smith ML, et al

    . Intermittent hypoxia: cause of or therapy for systemic hypertension? Exp Biol Med (Maywood) 2008;233:627–50 doi:10.3181/0710-MR-267 pmid:18408145

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Ghofrani HA,
    3. Voswinckel R,
    4. Reichenberger F, et al

    . Hypoxia- and non-hypoxia-related pulmonary hypertension: established and new therapies. Cardiovasc Res 2006;72:30–40 doi:10.1016/j.cardiores.2006.07.025 pmid:16934242

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Navarrete-Opazo A,
    3. Mitchell GS

    . Therapeutic potential of intermittent hypoxia: a matter of dose. Am J Physiol Regul Integr Comp Physiol 2014;307:R1181–97 doi:10.1152/ajpregu.00208.2014 pmid:25231353

    CrossRefPubMed
33. 33.↵
    2. Ellingsen I,
    3. Hauge A,
    4. Nicolaysen G, et al

    . Changes in human cerebral blood flow due to step changes in PAO2 and PACO2. Acta Physiol Scand 1987;129:157–63 doi:10.1111/j.1748-1716.1987.tb08054.x pmid:3554898

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Mardimae A,
    3. Balaban DY,
    4. Machina MA, et al

    . The interaction of carbon dioxide and hypoxia in the control of cerebral blood flow. Pflugers Arch 2012;464:345–51 doi:10.1007/s00424-012-1148-1

    CrossRefPubMed
35. 35.↵
    2. Balaban DY,
    3. Duffin J,
    4. Preiss D, et al

    . The in-vivo oxyhaemoglobin dissociation curve at sea level and high altitude. Respir Physiol Neurobiol 2013;186:45–52 doi:10.1016/j.resp.2012.12.011 pmid:23313855

    CrossRefPubMed
36. 36.↵
    2. Battisti-Charbonney A,
    3. Fisher JA,
    4. Duffin J

    . Respiratory, cerebrovascular and cardiovascular responses to isocapnic hypoxia. Respir Physiol Neurobiol 2011;179:259–68 doi:10.1016/j.resp.2011.09.004 pmid:21939786

    CrossRefPubMed
37. 37.↵
    2. Calamante F,
    3. Yim PJ,
    4. Cebral JR

    . Estimation of bolus dispersion effects in perfusion MRI using image-based computational fluid dynamics. Neuroimage 2003;19:341–53 doi:10.1016/s1053-8119(03)00090-9 pmid:12814584

    CrossRefPubMed
38. 38.↵
    2. Lassen NA,
    3. Andersen AR,
    4. Friberg L, et al

    . The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988;8:S13–22 doi:10.1038/jcbfm.1988.28 pmid:3192638

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Mouridsen K,
    3. Friston K,
    4. Hjort N, et al

    . Bayesian estimation of cerebral perfusion using a physiological model of microvasculature. Neuroimage 2006;33:570–79 doi:10.1016/j.neuroimage.2006.06.015 pmid:16971140

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Ostergaard L,
    3. Weisskoff RM,
    4. Chesler DA, et al

    . High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–25 doi:10.1002/mrm.1910360510 pmid:8916022

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Ostergaard L,
    3. Chesler DA,
    4. Weisskoff RM, et al

    . Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb Blood Flow Metab 1999;19:690–99 doi:10.1097/00004647-199906000-00013 pmid:10366200

    CrossRefPubMedWeb of Science